复星医药(02196.HK)：吴以芳辞任非执行董事

Core Viewpoint - Fosun Pharma announced the resignation of two key executives, which may impact the company's strategic direction and operational management [1] Group 1: Executive Changes - Wu Yifang has resigned from the position of non-executive director due to personal work changes, effective immediately upon delivery of the resignation letter to the board [1] - Zhou Xudong has resigned from the position of Senior Vice President for personal development reasons, effective September 30, 2025 [1]